Experienced in Cerebral Cavernous Malformation

Qingquan Hua

Department Of Otolaryngology Head And Neck Surgery, 
Wuhan, CN 
Experienced in Cerebral Cavernous Malformation
Department Of Otolaryngology Head And Neck Surgery, 
Wuhan, CN 
OverviewLocationsClinical Research

Overview

Qingquan Hua practices in Wuhan, China. Hua is rated as an Experienced expert by MediFind in the treatment of Cerebral Cavernous Malformation. Their top areas of expertise are Ear Cancer, Recurrent Respiratory Papillomatosis, Kimura Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Their clinical research consists of co-authoring 47 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Cerebral Cavernous Malformation.

Locations

Department Of Otolaryngology Head And Neck Surgery, Wuhan, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
Enrollment Status: Completed
Publish Date: November 25, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Standard of Care
Study Phase: Phase 3

47 Total Publications

Relationship Between Age at Diagnosis and Recurrence Characteristics in Adult-Onset Recurrent Respiratory Papillomatosis: A Nationwide Multicenter Study from China.
Relationship Between Age at Diagnosis and Recurrence Characteristics in Adult-Onset Recurrent Respiratory Papillomatosis: A Nationwide Multicenter Study from China.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hua's expertise for a condition
ConditionClose
        View All 22 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile